HAVN Life Sciences, Inc. is a biotechnology company, which provides psychedelic therapies through technology-focused, data-driven, and medical-based solutions. The firm engages in extraction of psychoactive compounds from plants and fungi and the development of natural health care products, and also mental health treatments to support mental health. The company was founded on April 8, 2020 and is headquartered in Port Moody, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of HAVN Life Sciences Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. HAVN Life Sciences Inc. market cap is $25,600.00.
What is the 52-week high for HAVN Life Sciences Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. HAVN Life Sciences Inc. 52 week high is $0.0052 as of September 06, 2025.
What is the 52-week low for HAVN Life Sciences Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. HAVN Life Sciences Inc. 52 week low is $0.00 as of September 06, 2025.
What is HAVN Life Sciences Inc. stock price today?
HAVN Life Sciences Inc. stock price today is $0.0071.
What was HAVN Life Sciences Inc. stock price yesterday?
HAVN Life Sciences Inc. stock price yesterday was $0.013.
What is the 50-day moving average of HAVN Life Sciences Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. HAVN Life Sciences Inc. 50-day moving average is $0.0011.